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Abstract: Pulmonary hypertension is called PH for short. It is caused by the pulmonary artery vascular disease leading
to pulmonary vascular resistance, and the increase right lung compartment load, which resulting in weakening or even
collapse of the right ventricular function. The establishment of rat PH model under the action of monocrotaline is a
repeatable, simple and accessible operation technique, which has been widely used in the treatment of pulmonary
hypertension. This paper discusses the principle and properties of the PH model on rats under the monocrotaline action.
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1. Introduction
Pulmonary hypertension is caused by an abnormal
increase in pulmonary blood pressure. The hemodynamic
criterion to identify the disease is measuring the average
pulmonary artery pressure of the right cardiac
catheter based on sea level and it should not be lower
than 25mm Hg in a calm state. This disease is generally
appeared because of pulmonary vascular lesions, which
increase pulmonary vascular pressure and right
ventricular after load, resulting in the weakening of the
right ventricular or even dysfunction.[1] The rats with
pulmonary hypertension formed under the monocrotaline
action are the ideal animal model for studying this
disease so far. Monocrotaline is a kind of bipyrrole
alkaloid. After it enters animal liver, it will undergo
certain biological enzyme transformation, flow through
with the blood to the lungs in the body, and cause
damage to the blood vessels in the lungs, resulting in
inflammation of the blood vessels. This reaction is
similar to the clinicopathological mechanism.[2]
After years of researches, people have new insights
towards the disease mechanism, but it still takes time to
fully understand the disease mechanism. A detailed
description of the disease's pathology is key to achieving
optimal productions, and PH animal models play an
important role in this process. Rat PH established by the
monocrotaline action under chronic hypoxia can be
utilized to study human PH. The mechanism of some
vascular lesions provoked by hypoxia is generally
mastered, while the circumstances of PH disease patients
with vascular blockage have not been found in the rat
model. The rat PH model technology developed under
the MCT action mechanism is characterized by
repeatability , low cost and simple operation, which is
the reason it is often applied in PH experiments.
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2. Pulmonary hypertension model
induced by monocrotaline
The rats with pulmonary hypertension formed under
the action of monocrotaline are an ideal animal model for
the pulmonary hypertension study. Monocrotaline is a
kind of bipyrrole alkaloid, which reacts with oxidase in
the liver with the blood flow to the lungs causing damage
to the pulmonary artery vessels, and this damage is
irreversible. There is a target cell called the endovascular
cell in the pulmonary artery, which is very significant for
the pulmonary artery. According to rats produced by
monocrotaline PAH lung tissue pathology model,
monocrotaline injection into animals will lead to the
swell phenomenon of pulmonary artery endothelial cells
in one week, and under electron microscope it can be
observed that the electron density decreases, the nucleus
will further increase, the cell membrane become thicker,
organelles are swollen again, and all these phenomenon
lead to the dysfunction of endothelial cell and it
gradually fall off. It can be seen by light microscopy that
the endothelial cells of pulmonary artery vessels
transform from their original flat state to a stereoscopic
state and protrude towards the lumen. After two or three
weeks, some of the endothelial cells of the pulmonary
artery vessels demonstrated necrosis or even shedding in
animals, and the pulmonary artery vessels manifested
fibrosis and sclerosis, resulting in narrowing of the
pulmonary artery vessels, thrombosis and blockage.
Another consequence is the imbalance between the
downstream vasodilatation and constriction of vessels,
leading to increased pressure in the pulmonary artery and
added pulmonary vascular resistance. In addition, in the
process of monocrotaline induced pulmonary artery
pressure, inflammation plays an important role and it
embodies in the following aspects in particular:
firstly, by the study of the monocrotaline pathology
model observation it can be found that number of
inflammatory cells infiltrate in model lung tissue, which
is similar to the vasculitis symptoms and it is mainly
around the blood vessels; secondly, the increase of
plasma proinflammatory factors in the monocrotaline
model was large, of which the tumor necrosis factor was
more obvious; thirdly, the utilization of
cyclophosphamide for preventive intervention can
effectively reduce the level of some inflammatory factors
on the culture medium of alveolar macrophages in the
monocrotaline model, such as interleukin 1, tumor
necrosis factor and interleukin 6. Finally, the infiltrating
and proliferating cells present in the lung tissue of
monocrotaline model were mostly mononuclear cells,
with a small number of T or B lymphocytes. Therefore,
nonspecific inflammation containing macrophages had
an important effect, pulmonary arterioles and capillaries
will be damaged by monocrotaline, and then
monocrotaline infused into alveolar interval induced
alveolar macrophage phagocytosis. In the meanwhile the
interleukin 1, tumor necrosis factor alpha and interleukin
6 proinflammatory factor used cascade amplification
reaction, and make the blood vessel walls and alveolar
interval by inflammatory cells infiltration with
mononuclear scavenger system activation repeatedly.
This increases the thickness of the vessel walls and
alveolar septa, and promoted the resistance of the
pulmonary vessels. Inflammatory response has important
impacts in the pathogenesis of the rat model of
pulmonary hypertension induced by monocrotaline.
Therefore, this model can be regarded as an animal
model closely related to the pathogenesis of connective
tissue-related pulmonary hypertension. At present, there
is no better model can be put into use, and it is the
optimal option based on practical application of the
model concerning monocrotaline-induced pulmonary
hypertension in rats to study the pathogenesis and drug
intervention of connective tissue-related pulmonary
hypertension.
3. Experimental study on
pulmonary hypertension
induced by monocrotaline
3.1 Experimental methods
(1) Grouping and modeling: 60 rats were randomly
divided into the control group (n=12) and the model
group (n=48). After 1 week adaptive feeding, 60mg/kg
subcutaneous injection of monocrotaline was carried out
in the model group, and then the hemodynamic indexes
were measured for 1, 2, 3 and 4 weeks with specimens
collected. 12 rats were collected at 4 different time points.
In the control group, the same amount of normal saline
was injected subcutaneously, and the pressure was
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measured again after 4 weeks of the injection, and then
the data were extracted.[3]
(2) Observe the basic conditions of rats: mainly
observe the feeding and activity of rats after injection of
monocrotaline, as well as the presence or absence of
infection and death, and weigh the rats after 4 weeks.
(3) Hemodynamic measurements: mean pulmonary
artery pressure was measured at week 1, 2, 3, and 4,
respectively, after injection of monocrotaline.
Thoracotomy was performed by placing a catheter in the
pulmonary artery via the right ventricle.
(4) Detection of right ventricular hypertrophy: the
rat heart was completely cut off, and after the atrial tissue
was removed, the A ventricle (RV) and the left ventricle
(RV) plus ventricular septum (LV+S) were separated, the
water was sucked dry with A filter paper, then the weight
was weighed and the RV/(LV+S) value was calculated.
(5) Detection of pulmonary vascular
micro-morphological indicators: the lung tissues were
fixed in negative pressure neutral formaldehyde for 24
hours, paraffin sections were prepared, and routine
hematoxylin-eosin staining was performed. Pulmonary
vascular morphology was observed under light
microscope in both groups. Calculation: 1. CMIAS
image processing and analysis system was used to
calculate the relative thickness of the medium (external
diameter 50 ~ 150 m) and small (external diameter 15 ~
50 m) muscular arteries. 2. Pulmonary vessel density per
unit area (per /mm).2
(6) Main observation indicators: changes of right
ventricular hypertrophy level, pulmonary vascular
micro-morphological indicators and hemodynamic
indicators in rats.
(7) Statistical analysis: statistical analysis was
carried out with the assistance of SPSS13.0 statistical
software, and the data were presented as x± s. P<0.05
was considered significant.
3.2 Discussion of experimental results
Inflammatory response plays a key role in the
pulmonary hypertension induced by monocrotaline.
Observation of the choline induced model pathology
showed that there was a large number of inflammatory
cell infiltration in the lung tissue of the model, which
was similar to the symptoms of vasculitis and mainly
distributed around the blood vessels. Plasma
proinflammatory cytokines in the model increased
significantly.
After 4 weeks of administration, the right
ventricle became hypertrophic and pulmonary artery
pressure increased significantly. Pulmonary vascular
remodeling, such as thickening of the middle membrane
of the pulmonary artery, increased myogenesis degree.
And intimal hyperplasia also appeared, which indicated
that an effective pulmonary hypertension model could be
established by induction of monocrotaline injection.[4]
Injecting monocrotalineinto into animals can reduce the
pulmonary vascular bed of animals and increase the
residual pulmonary blood flow, which is the same as the
changes in the pathological morphology of some blood
vessels such as pulmonary fibrosis, chronic obstructive
pulmonary disease and pulmonary embolism. When the
pulmonary vascular endothelium is injured, the
monocrotaline is selective and will lead to chronic
vascular inflammatory lesions. Compared with the model
of chronic hypoxia, this model is closer to the actual
clinical causes. In addition, the experimental model of
pulmonary hypertension in rats has better control over
the pathological process with lower mortality rate,
simple operation, and strong repeatability, which has
good promotion and application value.
4. Conclusion
Inflammatory response plays an important role in
the pathogenesis of the rat model of pulmonary
hypertension induced by monocrotaline. To some extent,
this model can be regarded as an animal model closely
associated with the pathogenesis of connective
tissue-related pulmonary hypertension. From the
practical standpoint, it is a rational choice to study the
pathogenesis and drug intervention of connective
tissue-related pulmonary hypertension in rats by using
monocrotaline model until a more suitable model is
developed.
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